The evaluation of right ventricular performance in different clinical models of heart failure

European Heart Journal, Supplement

Volumn 6, Issue 6, 2004, Pages

  Campana, Carlo ^a   Pasotti, Michele ^a   Monti, Lorenzo ^a   Revera, Miriam ^a   Serio, Alessandra ^a   Nespoli, Luisa ^a   Magrini, Giulia ^a   Scelsi, Laura ^a   Ghio, Stefano ^a   Tavazzi, Luigi ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

BNP; End stage heart failure; Pulmonary hypertension; Right ventricular function

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE MODEL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; PH; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; THERMODILUTION; WORLD HEALTH ORGANIZATION;

EID: 8644289475     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehjsup.2004.09.012     Document Type: Article

References (18)

1. R.A. Bleasdale, and M.P. Frenneaux Prognostic importance of right ventricular dysfunction Heart 88 2002 323 324
2. M. Hoeper, J. Tongers, and A. Leppert Evaluation of right ventricular performance with right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension Chest 120 2001 502 507
3. A. Maisel B-type natriuretic peptide levels a potential novel "White Count for congestive heart failure J Card Fail 7 2001 183 193
4. R. Latini, S. Masson, and I. Anand Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure. The Valsartan Heart Failure Trial (Val-HeFT) Circulation 106 2002 2454 2458
5. R.J. Barst, L.J. Rubin, and W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301
6. A.L. Hinderliter, P.W. Willis, and R.J. Barst Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary pulmonary hypertension study group Circulation 95 1997 1479 1486
7. R. Raymond, A. Hinderliter, and P. Willis Echocardiographic predictors of adverse outcome in primary pulmonary hypertension J Am Coll Cardiol 39 2002 1214 1219
8. E. Bossone, T. Duong-Wagner, and G. Paciocco Echocardiographic features of primary pulmonary hypertension J Am Soc Echocardiogr 12 1999 655 662
9. N. Nagaya, T. Nishikimi, and Y. Okano Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension J Am Coll Cardiol 31 1998 202 208
10. P.K. Shah, J. Maddahi, and H.M. Staniloff Variable spectrum and prognostic implications of left and right ventricular ejection fraction in patients with and without clinical heart failure and acute myocardial infarction Am J Cardiol 58 1986 387 393
11. J.F. Polak, B.L. Holman, and J. Wynne Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease J Am Coll Cardiol 2 1983 217 224
12. Y. Juilliere, G. Barbier, and L. Feldmann Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy Eur Heart J 18 1997 276 280
13. A. Gavazzi, C. Berzuini, and C. Campana Value of right ventricular ejection fraction in predicting short-time prognosis of patients with severe chronic heart failure J Heart Lung Transplant 16 1997 774 785
14. T.G. Di Salvo, M. Mathier, and M.J. Semigran Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure J Am Coll Cardiol 25 1995 1143 1153
15. J. Koglin, S. Pehlivanli, and M. Schwaiblmair Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J Am Coll Cardiol 38 2001 1934 1941
16. D. Mariano-Goulart, M.C. Eberlé, and V. Boudousq Major increase in brain natriuretic peptide indicates right ventricular systolic dysfunction in patients with heart failure Eur J Heart Fail 5 2003 481 488
17. R. Berger, M. Huelsman, and Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
18. M. Pasotti, C. Campana, and C. Klersy BNP nello scompenso cardiaco cronico di grado severo: correlazione con gli indici di funzione ventricolare destra Italian Heart J 4 2003 48S